260 results on '"Ferran, M."'
Search Results
2. Pityriasis Rubra Pilaris: A Multicentric Case Series of 65 Spanish Patients
3. Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real‐life clinical practice.
4. Dermatologists’ Role in the Early Diagnosis of Psoriatic Arthritis: Expert Recommendations
5. El papel del dermatólogo en el diagnóstico precoz de la artritis psoriásica: recomendaciones de un grupo de expertos
6. Linguistic and Cultural Adaptation to Spanish of the Screening Tool Psoriatic arthritis UnclutteRed Screening Evaluation (PURE4)
7. Adaptación lingüística y cultural al español del cuestionario Psoriatic arthritis UnclutteRed screening Evaluation (PURE-4)
8. 1542 Allergen sensitization status stratifies IL-31 production by memory T cells in atopic dermatitis
9. Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm Registry
10. Manejo de los tratamientos biológicos en pacientes con psoriasis moderada-grave sometidos a intervenciones quirúrgicas en el registro español Biobadaderm
11. 4CPS-235 Impact of telepharmacy on biologic therapies adherence and clinical outcomes in patients with psoriasis
12. [Translated article] Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience
13. Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over time
14. Immune-Mediated Inflammatory Diseases and Other Comorbidities in Patients With Psoriasis: Baseline Characteristics of Patients in the AQUILES Study
15. Enfermedades inflamatorias mediadas por inmunidad y otras comorbilidades en pacientes con psoriasis. Características basales de la cohorte de pacientes con psoriasis del estudio AQUILES
16. 053 SEB-induced IL-13 production in CLA+ memory T cells defines Th2 high and Th2 low responders in atopic dermatitis
17. Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience
18. 777 Heterogeneous il-9 production by circulating skin-tropic and non-tropic memory T cells in atopic dermatitis
19. Active tuberculosis in a cohort of patients with psoriasis on biologic therapy: learnings from real‐life medical practice
20. Clinical Characteristics and Disease Course in Patients Treated With Efalizumab Following Suspension of Marketing Authorization by the European Medicines Agency: A Multicenter Observational Study
21. BIOBADADERM, the Spanish Registry of Adverse Events Associated With Biologic Drugs in Dermatology: First Report
22. Perfil clínico y curso evolutivo de los pacientes tratados con efalizumab tras la suspensión de su autorización por la EMEA. Estudio observacional y multicéntrico
23. BIOBADADERM: registro español de acontecimientos adversos de terapias biológicas en Dermatología. Primer informe
24. Need for Touch and Multichannel Search and Purchase
25. INNOVATION IN DRUG TRAINING WITHIN NURSING DEGREE AT UNIVERSITAT ROVIRA I VIRGILI (URV): C062
26. Adverse Reactions During Biological Therapy for Psoriasis: Results of a Survey of the Spanish Psoriasis Group
27. Production of Interleukin 8 by Circulating CLA + T Cells With Skin Tropism in Patients With Psoriasis and in Healthy Controls
28. Efectos adversos observados durante la terapia biológica en la psoriasis. Resultados de una encuesta al Grupo Español de Psoriasis
29. Producción preferente de IL-8 por linfocitos T CLA+ circulantes con tropismo cutáneo en pacientes con psoriasis y en sujetos sanos
30. Use of biological treatments in patients with hidradenitis suppurativa
31. Indicadores de calidad asistencial en el paciente crónico en un centro de salud: evolución de 3 años
32. Indicadores de calidad asistencial de atención domiciliaria en un centro de salud: evolución en 3 años
33. Función efectora de linfocitos T CLA+ sobre queratinocitos autólogos en psoriasis
34. Effector Function of CLA+ T Lymphocytes on Autologous Keratinocytes in Psoriasis
35. Unmet needs in patients with moderate-to-severe plaque psoriasis treated with methotrexate in real world practice: FirST study.
36. Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicenter study by the Spanish Psoriasis Group
37. Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group
38. Vitamin D and cardiovascular health
39. Dermatologists' Role in the Early Diagnosis of Psoriatic Arthritis: Expert Recommendations
40. Linguistic and Cultural Adaptation to Spanish of the Screening Tool Psoriatic Arthritis UnclutteRed Screening Evaluation (PURE4)
41. Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-α blocker agents
42. Unmet needs in patients with moderate-to-severe plaque psoriasis treated with methotrexate in real world practice: FirST study
43. Real‐world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group
44. Production of IL-8 by circulant CLA+ T cell lymphocytes with skin tropism in psoriasis and healthy controls: P 157
45. Nodular lesion on the sole of the foot in a patient after a trip to Venezuela
46. Bilateral and symmetrical palmoplantar punctate keratoses in childhood: a possible clinical clue for an early diagnosis of PTEN hamartoma-tumour syndrome
47. Pseudotumoral primary syphilis on the tongue in an HIV positive patient
48. Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge
49. Acral papular neuromatosis: an early manifestation of Cowden syndrome
50. Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.